Evidence map›Paper›PMID 31348719›Full record

ArticleHuman vaccines & immunotherapeutics2019

Immunization with

Viviana Cobos Jiménez, Whitney Rabacal, Emily Rayens, Karen A Norris

Erratum issuedOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Journal of fungi (Basel, Switzerland) · 2022
    Review
  5. A therapeutic vaccine strategy to preventFrontiers in immunology · 2022
    Article
  6. Immune Response inJournal of fungi (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Pathogens (Basel, Switzerland) · 2021
    Review
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Viviana Cobos JiménezCenter for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia , Athens , USA.
Whitney RabacalCenter for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia , Athens , USA.
Emily RayensCenter for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia , Athens , USA.
Karen A NorrisCenter for Vaccines and Immunology, Department of Infectious Diseases, University of Georgia , Athens , USA.
University of Georgia · US

Funding

Prevention and Treatment of Pneumocystis PneumoniaR01AI148365 · NIAID · UNIVERSITY OF GEORGIA · PI NORRIS, KAREN A · 2020 to 2024
$3.7M
NIAID NIH HHS R01 AI148365
6 · The paper itself

Abstract

Infection with the opportunistic fungal pathogen,

Indexed as

Immunity, HumoralImmunocompromised HostAnimalsFemaleFungal VaccinesHIV InfectionsImmunizationImmunologic MemoryImmunosuppression TherapyMacaca mulattaPneumocystis cariniiPneumonia, PneumocystisProof of Concept StudySerine EndopeptidasesFungal VaccinesKex1 protein, Pneumocystis jiroveciiSerine EndopeptidasesimmunosuppressionKexinNHPPneumocystistacrolimusvaccine

Identifiers

PMID31348719
PMCPMC6773377
OpenAlexW2965237601

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.